OrthoNetx, Inc., a privately-held, Colorado-based leading provider of medical devices for osteoplastic surgery, today announced that Robert S. Corrigan has joined the company’s Board of Directors as an outside Director.

“Bob has significant experience in investment banking and corporate finance,” said Terry R. Knapp, President and Chief Executive Officer of OrthoNetx, Inc. “His guidance will be invaluable as we evaluate various growth strategies and pursue new opportunities.”

Mr. Corrigan has been in the financial services and corporate finance industry for over 20 years. Currently and for the last 12 years, Mr. Corrigan has served as Chairman and Chief Executive Officer of Centennial Capital Group, Inc., a Boulder, Colorado based investment banking enterprise which assists developmental stage and other companies in corporate finance, mergers and acquisitions and business development.

“OrthoNetx has many of the key components for success that I look for when working with new companies,” said Mr. Corrigan. “They are in an exciting market, have innovative solutions, and a strong management team with a proven track record. I look forward to working closely with them as we expand the organization.”

Prior to founding Centennial Capital Group, Inc., Mr. Corrigan was employed by the major financial services companies of Merrill Lynch, Pierce Fenner & Smith, Inc. and Paine Webber, Inc. Mr. Corrigan has been and is currently a board member and/or advisory board member to numerous private and public companies including his 1987 appointment to the Paine Webber Direct Investments Advisory Board. Mr. Corrigan holds a BS degree from Castleton State College, Castleton, Vermont and an MS from Youngstown State University, Youngstown, Ohio.

On September 6, 2005 OrthoNetx, Inc., announced it has signed a definitive merger agreement with Eye Dynamics, Inc. (OTCBB:EYDY), a leading provider of health and safety products, with Dr. Knapp to lead the merged companies as CEO.

About OrthoNetx, Inc.
OrthoNetx, Inc. designs, develops, manufactures and markets patented, FDA-approved medical devices and systems for osteoplastic surgery and distraction osteogenesis-the practice of generating, forming and molding bone. Physician customers include plastic surgeons, oral and maxillofacial surgeons, otolaryngologists, and orthopedic surgeons who correct deformities and deficiencies of the skeleton caused by errors of birth, trauma, infections and tumors. OrthoNetx, Inc. is also developing a “smart device” process management system to support a broad range of medical devices that leverage the body’s physiological and biological attributes to create medical benefits. The privately-held company is headquartered in Superior, CO. From more information visit: www.orthonetx.com.

Safe Harbor for Forward Looking Statements

This news release includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.